載入...
Patient-reported Outcomes in Metastatic Castration-sensitive Prostate Cancer in the Adjuvant Setting
We review the importance of quality of life (QOL) data from patient-reported outcome measures (PROMs) among men treated with androgen deprivation therapy (ADT) for metastatic castration-sensitive prostate cancer (mCSPC) or localized prostate cancer treated with adjuvant therapy. This information is...
Na minha lista:
| 發表在: | Eur Urol Focus |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6658671/ https://ncbi.nlm.nih.gov/pubmed/30612936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.euf.2018.12.007 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|